Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diquafosol for OK Lens Related Dry Eye
NCT06537349Not yet recruiting
- Sponsor
- He Eye Hospital
- Start
- Aug 2024
- Primary completion
- Dec 2024
- Modality
- Small Molecules
01
Overview
Open-label, single-arm trial of diquafosol in dry eye syndrome (DED), sponsored by He Eye Hospital. Primary endpoint: Pediatric Refractive Error Profile at 4 weeks. Planned start Aug 2024; status: not yet recruiting.
02
Drugs
diquafosol
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT06537349.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06537349.